We observed that the percentage of CD8+CD25+ T cells was decreased in the patients with moderate AD compared with that in the mild AD patients (Fig. 3B), suggesting defective terminal differentiation of effector T cells. This evidence concerns the gene CD8A and Alzheimer disease.